Broom Colin MD 4
4 · Nabriva Therapeutics plc · Filed Sep 3, 2019
Insider Transaction Report
Form 4
Broom Colin MD
Chief Executive Officer
Transactions
- Purchase
Ordinary Shares
2019-08-30$2.03/sh+10,177$20,668→ 208,750 total
Footnotes (2)
- [F1]The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,177 shares, with the reporting person's sale of 10,177 ordinary shares at a price of $2.07 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $397.93, representing the full amount of the profit realized in connection with the short-swing transaction.
- [F2]This amount represents the reporting person's total holdings of ordinary shares of the Issuer, including 72,849 ordinary shares formerly held indirectly by the reporting person in a grantor retained annuity trust. The grantor retained annuity trust has been terminated and the ordinary shares have been returned to the direct ownership of the reporting person.